Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Seven, Ekim
DANNOAC-VTE, NCT03129555: The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism	Recruiting	4	5000	Europe	Dabigatran Etexilate Oral Capsule, Rivaroxaban Oral Tablet, Edoxaban Oral Tablet, Apixaban Oral Tablet	Herlev and Gentofte Hospital, Danish Society of Cardiology	Deep Vein Thrombosis, Pulmonary Embolism	03/27	03/29
DANNOAC-AF, NCT03129490: The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation	Recruiting	4	11000	Europe	Dabigatran Etexilate Oral Capsule, Rivaroxaban Oral Tablet, Edoxaban Oral Tablet, Apixaban Oral Tablet	Herlev and Gentofte Hospital, Danish Society of Cardiology	Atrial Fibrillation, Atrial Flutter	10/27	10/27
ASTERIx, NCT05061355: Antibiotics Vs Antibiotics and Surgical ThERapy for Infective Endocarditis	Recruiting	N/A	496	Europe	Heart valve surgery	Emil Loldrup Fosbol, Herlev and Gentofte Hospital, Bispebjerg Hospital, Amager Hospital, Nordsjaellands Hospital, Copenhagen University Hospital, Hvidovre	Endocarditis Infective	06/26	06/26